Loading clinical trials...
Loading clinical trials...
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide: Randomized Double Blind Placebo Controlled Trial
One of the most common complaints of admission to the emergency room is gastroenteritis. One of the most common complaints in acute gastroenteritis is abdominal pain. The aim of our study is to investigate whether hyoscine butylbromide used within the indication has an effect on abdominal pain due to acute gastroenteritis. The main purpose of our study is to reduce the pain of the patient at 30th and 60th minutes compared to 0th minute.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Ankara City Hospital
Ankara, Turkey (Türkiye)
Start Date
September 8, 2021
Primary Completion Date
December 3, 2021
Completion Date
January 3, 2022
Last Updated
January 4, 2022
50
ACTUAL participants
Hyoscine N Butylbromide
DRUG
Placebo
OTHER
Lead Sponsor
Ankara City Hospital Bilkent
NCT03823742
NCT07008092
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions